It is difficult to make prognoses and decisions on therapy of individuals with congenital heart disease (CHD) and plan efficiently for medical services 
Prevalence rates defect
Age at death DESPITE NUMEROUS STUDIES on the natural history of congenital heart disease (CHD), many details are still lacking for planning medical services and prognosticating immediate and long-term results of surgical treatment compared to results of medical or no treatment. This information could ideally come from intensive prospective studies of large populations for each type of CHD to determine its incidence at birth and its effects in childhood and adulthood, with or without surgical intervention. From No such study has been made since suitable diagnostic techniques have only recently become available and the majority of intensive studies have been on small and unrepresentative populations. One of the objectives of this paper is, therefore, to assess the reliability of different types of studies which purport to supply information about the natural history of CHD.
One special aspect of this problem deals with the incidence of spontaneous closure of ventricular septal defect (VSD), first described in 19181; decrease in the size of the VSD was first demonstrated by cardiac catherization in 1958.2 Thereafter, sporadic reports of spontaneous closure proven by cardiac cathet'-rization appeared3-7; closure occurred HOFFMAN even in the presence of large left-to-right shunts, high (or even systemic) pulmonary arterial pressure, and congestive heart failure. 3, 4, 7 In 1960, Evans and associates3 reported that the high-pitched murmur of a small VSD disappeared in 37 of 120 children, and in similar studies, in 1964, Ash8 found that 25 of 160 infants with small VSD subsequently lost all signs of heart disease. In the same year Bloomfield9 combined clinical, cardiac catherization and autopsy data from an older population; he concluded that spontaneous closure might occur in as many as 25% of all infants born with VSD and that it could also occur in adult life. The frequency of spontaneous closure of VSD in these studies cannot be applied to all persons with VSD, since none of the investigations were in an unselected series followed from birth. This conclusion was supported by a report'0 of 39 children with VSD who were followed from birth; all of them were catheterized and almost all had the classical VSD murmur, though only some had symptoms. A few who had the soft blowing murmur of a very small VSD3 8, 11 were also observed but were not catheterized nor included in the study. In 15 (38%) the defect closed spontaneously; closure was commoner in the smaller defects and usually took place before 12 months of age. Since the frequency and time of spontaneous closure of VSD have great significance in deciding on management of patients with VSD, the second objective of this paper is to determine how much reliable information there is about these matters.
Incidence of CHD Incidence in Live Births
This has been investigated by studying groups of infants in the neonatal period, following groups of children for several months or years, or trying to detect all who have had CHD in a group of children born during a particular period. All these methods have serious defects.
Neonatal Studies
Large populations can be sampled when congenital malformations can or must be noted on birth or supplementary certificates, but this method grossly underestimates their true incidence. One major reason for this underestimation is that known lesions are often not reported. Lilienfeld and associates12 found that only 34% of newborns with birth injuries or congenital malformations mentioned in their hospital records had this information on their birth certificates; more recently, Bierman and associates13 found the proportion to be under one third. This may explain, in part, why Gentry and associates '4 found the incidence of CHD reported on birth certificates to be 0.72/1,000 live births, while on death certificates for the same period it was 2.18/1,000, that is, only 33% of those who died from CHD had been certified as born with it. Similarly, Osterud and associates'5 found CHD reported on birth certificates in 0.77/1,000 live births, but it was recorded in only 25% of the birth certificates of those children under 5 years whose death certificates mentioned CHD. Greater disparity is shown in figures from age, namely, 37 weeks; full-term infants weighing less than 2,500 g have been termed "underweight," "small-for-date," and "intrauterine dwarfs." The difference in incidence of these two groups is illustrated in the study by Bierman Data from general hospitals are also subject to a minor but significant computational artifact in that deaths after the first decade are usually grouped in decades or as all over 10 the same age range in three populations (table 15), the autopsy ratios vary from about half to twice the more representative population ratios at similar periods. In reported autopsies on persons over 20 years of age (table 14) , CHD prevalence is 1 to 13/1,000 autopsies; the high rates may represent an undue concentration of CHD due to local interest while the lowest rates may be lower than the ratio in the population. If about 50 to 60% of children born with CHD survive childhood25' 26 and if the incidence of CHD at birth is 8 to 10/1,000 live births, then about 4 to 6 children with CHD/ 1,000 live births should survive to adult life. For children born without CHD the chance of surviving to adult life are about 950/1,000,21 so that the prevalence rate of CHD in adults should be about 4 to 6/1,000. If Kerrebijn's figures27 are used, the prevalence rate of CHD in adults ought to be 6 to 8/1,000. Both these rates are considerably in excess of the lowest prevalence rates in the autopsy series (table  14) ; the falsely low rates might be due either to unrepresentative sampling or to a high mortality rate in childhood from CHD many years ago, so that few people with CHD lived long enough to be included in an autopsy survey of adults. With all these possible sources of variation in autopsy series it is difficult to draw conclusions from the proportion of CHD in autopsy series. There is certainly no justification in the common practice of pooling the numbers of autopsies from CHD and from other diseases to obtain an average from several series which can in no meaningful way be compared.
Mortality Rates of Specific Types of CHD
The mortality rates for specific types of CHD should be determined by following groups of children from birth or, failing that, by intensive registry studies in which as many as possible of the living and dead with that type of CHD are detected. Data from the latter type of study25' 26 (table 16 ) are subject to the same limitations as the data for CHD in general. The Liverpool series26 has been followed for less time than that in Gothenburg,25 but since most deaths occur below 5 years of age, this introduces little error. Considering the relatively small sample sizes, the mortality rates are similar for most lesions, the predominant discrepancies being for PDA, aortic stenosis, coarctation of the aorta, tetralogy of Fallot, and tricuspid atresia.
For each type of CHD most deaths occur within the first year after birth, the majority being in the first month (table   17) . 25 ence between mortality rates reported from children's hospitals25' 32 or general hospitals. 47 55, 56 When prolonged life is possible, such as VSD, ASD, and tricuspid atresia with transposition of the great arteries, differences will depend on where the series is obtained. Early deaths occur in both series, but since older deaths come more from general hospital series, the proportion of early deaths will be less in them. There may even be a greater tendency for autopsy to be performed on older persons with CHD because of the relative rarity of CHD in adults, so that they may be overrepresented in a general hospital series.
It is often difficult to decide whether death is due to CHD. Thus, finding a PDA or an ASD in an infant at autopsy does not show that the cardiac lesion caused death. To show that it did, there should be supportive autopsy and clinical evidence which, however, are seldom mentioned in reported series. In many types of CHD, death may be predominantly due to prematurity, infection, or noncardiac malformations so that the need for early treatment of CHD cannot be judged from mortality figures alone. Furthermore, predictions of the natural history of a single anatomic type of CHD from mortality rates ignore the wide range of physiological differences involved. For example, the course of a mild coarctation of the aorta cannot be predicted from mortality rates for more severe coarctations, and what happens to a small VSD cannot be foretold by extrapolation of what happens to a mixture of large and small VSD. The average mortality rate for VSD (0.22/ 1,000 live births) is 11% of the estimated incidence of VSD at birth (2/1,000 live births). This is lower than that in the studies quoted in table 18, probably because many children whose VSD closed spontaneously were never referred to the clinic or registry so that the prevalence of VSD known to the investigator was less than the incidence at birth. The possible magnitude of this error can be shown from one study'0 in which 10/31 VSD closed spontaneously before 1 year of age. If these had not been detected before closure, the estimated mortality rate for VSD in that study would were not due to VSD (personal communication); this was also the conclusion of Keith Mortality rates and proportional mortality rates for VSD and CHD have often been derived from autopsy series, possibly because they are easier to investigate. It is necessary to determine the value of these studies, however, for in few places are all deaths submitted to autopsy examination. In general, the proportion of deaths from CHD which show VSD is much less in registry series (table 18)  than in autopsy series (table 20) . The variation depends on the ages of the persons examined, the proportion of premature or stillborn infants (the latter having a higher proportion of VSD, table 21), and the relative autopsy rates for all CHD and for VSD. Without knowing how to assess these factors, it is difficult to ascribe much meaning to the data from autopsy series.
VSD in Adults
It is difficult to know whether the VSD prevalence rate in adult autopsy series (table  22) represents its prevalence in all adults since adults with loud murmurs who die might be more apt to have an autopsy examination. There were 35 instances of VSD in persons over 20 years in 141,057 autopsies; some autopsy series did not separate children, but by taking 75% of their totals, the estimated corrected total autopsies on persons over 20 years is 110,812 and the prevalence rate of VSD per 1,000 autopsies on persons over 20 years would then be 0.31/1,000. There is, however, some evidence that recognition and reporting of CHD are far from complete, as noted in several surveys in which .all or almost all of a designated group were examined. Not only are the prevalence figures usually greater (4.6 to 6.9/1,000, When the total number of autopsies included persons of all ages, the rate per 1,000 deaths at over 20 years of age was estimated by assuming that 75% of all autopsies were performed on persons over 20 years old. The natural history of any congenital malformation begins when that malformation is first determined or else manifested in the very early embryo. Should these malformaCircLlation, Volume XXXV'lI, January 1968 120) tions be associated with fetal death out of proportion to other causes of fetal death, then the incidence of malformations at birth will not be the same as their incidence in the fetus. It would be possible for an increased fetal incidence of a malformation to be compensated for by an increased fetal death rate due to or associated with it so that the incidence at birth might be unaltered; by noting only incidence in live births, valuable clues to the cause of the malformation might therefore be lost. There is evidence that CHD occurs more often in stillborn than in live-born children, so that there is need for more intensive studies of the incidence of CHD (and other malformations) in stillborn infants.
Prematurity is also associated with an increased incidence of CHD. Sometimes prematurity might cause or reveal the lesion, such as VSD37 or PDA; at other times prematurity might merely provide more prolonged and intensive care during which CHD might be detected, and there are probably some children in whom the factors causing the CHD are also responsible for the prematurity. Very few studies of CHD mention prematurity, and this now needs to be done so that correction can be made for undue proportions of premature infants in a series and in order to assess why the CHD is related to prematurity. An attempt should also be made to distinguish prematurity as judged by gestational age from that more conventionally judged by birth weight. Not only may these two groups have different subsequent courses and mortality rates (Bierman and associates'3), but the differences may throw some light on why CHD is more common in premature children, hitherto almost always defined in terms of birth weight without regard to gestational age.
The incidence at birth of CHD and its subdivisions can best be made by intensive continuing studies of cohorts of infants from birth by pediatricians, cardiologists, and epidemiologists. One study of this type is now being conducted as the Collaborative Study on Cerebral Palsy and Mental Retardation,37 but more are required in other countries to deterCirculation, Volume XXXVII, January 1968 mine possible regional variations. More attention should also be paid to differentiation by parental age and health, socio-economic class, and birth order to try to define possible causal associations. It is of interest that current estimates of the incidence of CHD from Sweden, Japan, the United States, Holland, and Finland are similar, but variations in the methods of collecting data make it difficult to decide whether real differences are being masked. More should also extend to early and late results of various surgical procedures. At present we have to make decisions about prognosis and treatment on insufficient evidence, and it will take another 50 years of careful follow-up of each variety of CHD, with anatomic and physiological variations distinguished, before giving definite answers to some of the questions which are now being asked.
